Serelaxin: insights into its haemodynamic, biochemical, and clinical effects in acute heart failure

Affiliations

¹ Postgraduate School, Universidad Peruana de Ciencias Aplicadas (UPC), Lima 27, Peru; and Health Outcomes and Clinical Epidemiology Section, Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Editorial

Adrian V Hernandez. Eur Heart J. 2014 Feb.

. 2014 Feb;35(7):410-2.

doi: 10.1093/eurheartj/eht477. Epub 2013 Nov 24.

¹ Postgraduate School, Universidad Peruana de Ciencias Aplicadas (UPC), Lima 27, Peru; and Health Outcomes and Clinical Epidemiology Section, Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

No abstract available

Comment on

A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure.
Ponikowski P, Mitrovic V, Ruda M, Fernandez A, Voors AA, Vishnevsky A, Cotter G, Milo O, Laessing U, Zhang Y, Dahlke M, Zymlinski R, Metra M. Ponikowski P, et al. Eur Heart J. 2014 Feb;35(7):431-41. doi: 10.1093/eurheartj/eht459. Epub 2013 Nov 18. Eur Heart J. 2014. PMID: 24255129 Free PMC article. Clinical Trial.